Results 281 to 290 of about 1,700,721 (365)

The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6‐step model of rational pharmacotherapy in a Turkish medical school

British Journal of Clinical Pharmacology, EarlyView.
Aims At Koç University School of Medicine, a one‐week rational pharmacotherapy (RPHM) programme, modelled after WHO 6‐step, has been introduced in the fourth‐year curriculum to improve prescription skills. For efficient problem‐based learning (PBL) sessions on a prespecified topic, students need to brush up on basic pharmacology knowledge, so we ...
Sinem Ezgi Gülmez, Gülnihal Özcan, Hakan S. Orer   +2 more
wiley   +1 more source

Perspectives of adult advanced pre-dialysis chronic kidney disease patients about kidney replacement therapy in three referral hospitals in Rwanda. [PDF]

BMC Nephrol
Shumbusho G, Nyenyeri DL, Kabahizi J, Uwiragiye D, Habyarimana O, Binayisa G, Nyirangirimana A, Twagirumukiza E, Neil KL, Deyessa N, Leichtman A, Murayire J, Dufatanye E, Nkundimana G, Sebera E, Elbasha AM.   +15 more
europepmc   +1 more source

Electronic medicine management systems in developing countries: A landscape review

British Journal of Clinical Pharmacology, EarlyView.
Medicines are a major global health expense. However, suboptimal use increases costs and causes patient harm. One way to reduce costs and increase safe, efficient medicines use is with electronic medicines management systems (EMMS). They allow easy capture of routine health data which can facilitate research, service planning and reimbursement ...
Andrew Lambarth, Dalia Wainwright, Trisha Saha, Millicent Banks, Iona Minty, P.A.M.K. Abeywickrama, Reya V. Shah, Yogini Jani, Reecha Sofat   +8 more
wiley   +1 more source

Transfer learning for mortality risk: A case study on the United Kingdom. [PDF]

PLoS One
Nalmpatian A, Heumann C, Alkaya L, Jackson W.   +3 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Latent profile analysis of social participation among adults with cardiovascular disease based on the CHARLS. [PDF]

Sci Rep
Zhu S, Yang W, Ma A, Wang L, Zhao T, Gao X.   +5 more
europepmc   +1 more source

Economies of Scale in Italian Non-Life Insurance [PDF]

The Geneva Papers on Risk and Insurance - Issues and Practice, 1991
openaire   +2 more sources

Choice and diversity in governance in the English alternative provision sector: Implications for educational equity

British Educational Research Journal, EarlyView.
Abstract Despite the continued global prevalence of discourses of educational inclusion, young people across local, national and international contexts continue to be educated outside of mainstream schools. In England, a diverse market of providers—known as alternative provision (AP)—cater for many of these young people.
Jodie Pennacchia, Mark Axler, Stephanie King, Andrew Clapham   +3 more
wiley   +1 more source

Health-Related Quality of Life of Non-Small Cell Lung Cancer Patients Treated with Targeted Therapy: Based on the EQ-5D-5L Scale in Vietnam. [PDF]

Asian Pac J Cancer Prev
Nguyen CV, Nguyen HTT, Luu Nguyen TN, Dao LK, Tran Thi HT, Pham Huy KT.   +5 more
europepmc   +1 more source

GEMAct: a Python package for non-life (re)insurance modeling [PDF]

Gabriele Pittarello, Edoardo Luini, Manfred Marvin Marchione   +2 more
openalex   +1 more source